跳至主要内容
临床试验/NCT00259584
NCT00259584已完成1 期

A Prospective Longitudinal Study of the Management and Outcome of Superior Vena Caval Obstruction (SVCO)

University Health Network, Toronto1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2001年10月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Improvement in an index symptom at 4 weeks as recorded by a daily symptom diary

研究概览

简要总结

All patients with symptomatic malignant SVCO deemed suitable for treatment either with radiation therapy or by stenting will be eligible. They will receive whichever treatment is deemed most clinically appropriate. Symptomatic response, time to onset of palliation, duration of symptom control and survival will be assessed.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Symptomatic clinical and radiological diagnosis of superior vena caval obstruction.
  • •Underlying histological diagnosis deemed appropriate for palliative radiotherapy as treatment by investigator. Patients with chemosensitive tumours such as small cell lung cancer (both untreated and recurrent), lymphoma and testicular tumours, will be eligible if radiation is deemed to be appropriate treatment.

排除标准

  • 未提供

结局指标

主要结局

Improvement in an index symptom at 4 weeks as recorded by a daily symptom diary

次要结局

  • Time to onset of palliation
  • Duration of symptom control
  • Survival
  • Number of days spent in hospital
  • Requirement for further treatment

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验